CANF Competitors & Alternatives
Compare Can Fite Biopharma Ltd ADR with similar stocks in the same industry
Biotechnology
CANF
Main Stock$2.33
Tradestie Score
46
Market Cap
$9.67M
Revenue Growth
-0.4%
Analyst Upside
+243.3%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANRO
Alto Neuroscience Inc.
|
$32.00
|
$110.20M | - | 48 | Compare |
|
IRD
Opus Genetics, Inc. Common Stock
|
$6.04
|
$107.83M | - | 38 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 49 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$10.22
|
$71.32M | - | 43 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$12.14
|
$67.94M | - | 42 | Compare |
|
BLRX
BioLineRX Ltd
|
$2.51
|
$16.50M | - | 49 | Compare |
|
RDHL
Redhill Biopharma Ltd.
|
$0.64
|
$8.39M | - | 37 | Compare |
|
CETX
CEMTREX INC.
|
$2.43
|
$4.26M | - | 48 | Compare |
|
HEPA
HEPA
|
- | - | - | - | Compare |
|
CFOR
CFOR
|
- | - | - | - | Compare |
More CANF Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2834)
239 stocks in this industry